Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
cephalosporin |
| gptkbp:ATCCode |
J01DD12
|
| gptkbp:CASNumber |
62893-19-0
|
| gptkbp:chemicalFormula |
C25H27N9O8S2
|
| gptkbp:combines |
gptkb:sulbactam
|
| gptkbp:contraindication |
hypersensitivity to cephalosporins
|
| gptkbp:discoveredBy |
gptkb:Fujisawa_Pharmaceutical
|
| gptkbp:eliminationHalfLife |
1.5-2 hours
|
| gptkbp:excretion |
renal
biliary |
| gptkbp:generation |
cephalosporin
|
| https://www.w3.org/2000/01/rdf-schema#label |
cefoperazone
|
| gptkbp:introducedIn |
1981
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits bacterial cell wall synthesis
|
| gptkbp:molecularWeight |
667.7 g/mol
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:proteinBinding |
82-93%
|
| gptkbp:routeOfAdministration |
intramuscular
intravenous |
| gptkbp:sideEffect |
diarrhea
elevated liver enzymes allergic reactions |
| gptkbp:spectrumOfActivity |
broad-spectrum
|
| gptkbp:usedFor |
bacterial infections
|
| gptkbp:bfsParent |
gptkb:sulbactam
|
| gptkbp:bfsLayer |
7
|